Document:

Document

EXHIBIT 10.35

HUNTINGTON INGALLS INDUSTRIES, INC.
AMENDED AND RESTATED DIRECTORS' COMPENSATION POLICY

Directors of Huntington Ingalls Industries, Inc., a Delaware corporation (the "Company"), who are not employed by the Company or one of its subsidiaries (''non-employee directors") are entitled to the compensation set forth below for their service as a member of the Board of Directors (the "Board") of the Company. The Board has the right to amend this policy from time to time.
						
	Cash Compensation	
	Annual Retainer	$100,000
	Additional Non-Executive Chairman Retainer	$250,000
	Additional Committee Chair Retainers	
	Audit Committee Chair	$25,000
	Compensation Committee Chair	$20,000
	Governance and Policy Committee Chair	$20,000
	Finance Committee Chair	$20,000
	Cybersecurity Committee Chair	$20,000
	Additional Audit Committee Member Retainer	$17,500
	Additional Compensation Committee Member Retainer	$7,500
	Additional Governance and Policy Committee Member Retainer	$7,500
	Additional Finance Committee Member Retainer	$7,500
	Additional Cybersecurity Committee Member Retainer	$7,500
		
	Equity Compensation	
	Annual Equity Award	$160,000

Cash Compensation

Each non-employee director will be entitled to an annual cash retainer while serving on the Board in the amount set forth above (the "Annual Retainer"). A non-employee director who serves as the Non-Executive Chairman of the Board will be entitled to an additional annual cash retainer while serving in that position in the amount set forth above (the "Additional Chair Retainer"). A non-employee director who serves as the Chairman of the Audit Committee, the Compensation Committee, the Governance and Policy Committee, the Finance Committee or the Cybersecurity Committee of the Board will be entitled to an additional annual cash retainer while serving in that position in the applicable amount set forth above (an "Additional Committee Chair Retainer''). A non-employee director who serves as a member of the Audit Committee, the Compensation Committee, the Governance and Policy Committee, the Finance Committee or the Cybersecurity Committee of the Board (other than as the Chairman of the applicable committee) will be entitled to an additional cash retainer while serving as a member of that committee in the applicable amount set forth above (the "Additional Committee Member Retainer").

The amounts of the Annual Retainer, Additional Chair Retainer, Additional Committee Chair Retainers and Additional Committee Member Retainers reflected above (collectively, the “Annual Cash Retainers”) are expressed as annualized amounts. These retainers will be paid on a quarterly basis, at the end of each quarter in arrears. The retainer for a non-employee director for a particular quarter will be pro-rated if the non-employee director serves (or serves in the corresponding position, as the case may be) for only a portion of the quarter (with the proration based on the number of calendar days in the quarter that the director served as a non-employee director or held the particular position, as the case may be).

Notwithstanding the foregoing, a non-employer director may elect under the terms of the Board Deferred Compensation Policy to receive his or her Annual Cash Retainers for the following calendar year in the form of stock units. The stock units will generally become payable within 30 days following the date the non-employee director ceases to provide services as a member of the Board; provided, however, a non-employee director who has met his or her Ownership Guideline (as defined below) as of the Measurement Date (as defined below) may elect under the terms of the Board Deferred Compensation Policy to receive his or her Annual Cash Retainers for the following calendar year in the form of stock units that are payable in the fifth calendar year after the year in which the Annual Cash Retainers are earned (or upon the director’s separation from service from the Board, if earlier). The number of stock units will be determined by dividing (1) the portion of the Annual Cash Retainers to which the electing non-employee director is otherwise entitled for a given calendar quarter by (2) the per-share closing price (in regular trading) of the Company’s common stock on the New York Stock Exchange on the last day of such 
1

quarter (or, if such day is not a trading day, the most recent prior trading day), rounded down to the nearest whole unit. The stock units will be subject to the terms of the Board Deferred Compensation Policy.

Annual Equity Awards
On the first trading day of each fiscal quarter of the Company, each non-employee director then in office will automatically be granted an award of stock units determined by dividing (1) one-quarter (1/4) of the Annual Equity Award grant value set forth above by (2) the per-share closing price (in regular trading) of the Company's common stock on the New York Stock Exchange on the date of grant, rounded down to the nearest whole unit.

Each stock unit award will be made under and subject to the terms and conditions of the Company’s 2012 Long-Term Incentive Plan or any successor equity compensation plan approved by the Company's stockholders and in effect at the time of grant (the “Plan”), and will be evidenced by, and subject to the terms and conditions of, an award certificate in the form approved by the Board to evidence such type of grant pursuant to this policy. Each award will be fully vested at grant and will generally become payable within 30 days following the date the non- employee director ceases to provide services as a member of the Board. Non-employee directors are entitled to receive dividend equivalents with respect to outstanding and unpaid stock units granted pursuant to this policy.
Dividend equivalents, if any, are paid in the form of a credit of additional stock units under the Plan and are subject to the same vesting, payment and other provisions as the underlying stock units.

Notwithstanding the foregoing, if a non-employee director beneficially owns shares of the Company’s common stock (his or her “Beneficial Ownership”) with a value equal to at least five times (5x) the director’s annual cash retainer (the “Ownership Guideline”) as of the date of the last quarterly grant of the Annual Equity Award for a given year (the “Measurement Date”), the non-employee director may elect under the terms of the Board Deferred Compensation Policy to receive his or her Annual Equity Award for the following calendar year in the form of either
(a) shares of the Company’s common stock (with the number of shares being equal to the number of stock units the director would have been granted on each quarterly grant date, but for the election) or (b) stock units that are payable in the fifth calendar year after the year in which the Annual Equity Award is earned (or upon the director’s separation from service from the Board, if earlier). The common stock or stock units, as the case may be, will be fully vested on the date of grant and will be issued under (and subject to the terms of) the Plan and the stock units will further be subject to the terms of the Board Deferred Compensation Policy. If the non-employee director elects to receive common stock and the non-employee director’s Beneficial Ownership is less than the Ownership Guideline as of any quarterly grant date in the following calendar year, the non-employee director will be required to retain all of the common stock received on that quarterly grant date (net of taxes) until the next Measurement Date on which his or her Beneficial Ownership is greater than the Ownership Guideline.

Any stock units credited to a non-employee director (including in an account under the Board Deferred Compensation Policy), any shares owned by a non-employee director, the non-employee director’s spouse or minor children, and any shares owned by a trust for the benefit of a non-employee director or his or her family shall count as shares beneficially owned by a non-employee director for purposes of the Ownership Guideline.

The foregoing general provisions are, in the case of a particular award, subject to the terms and conditions of the applicable award certificate.
Expense Reimbursement
All non-employee directors will be entitled to reimbursement from the Company for their reasonable travel (including airfare and ground transportation), lodging and meal expenses incident to meetings of the Board or committees thereof or in connection with other Board-related business.

Such benefits and reimbursements are not subject to liquidation or exchange for another benefit and the amount of such benefits and reimbursements that the non-employee director receives in one taxable year shall not affect the amount of such benefits or reimbursements that the non-employee director receives in any other taxable year. The non-employee director shall promptly provide the Company with reasonable written substantiation for any such expenses. The Company shall pay any such reimbursement to the non-employee director promptly after its receipt of such documentation and in all events not later than the end of the calendar year following the year in which the related expense was incurred.

Effective December14, 2021

2
2Exhibit 10.1

 

STOCK PURCHASE AGREEMENT

 

THIS STOCK PURCHASE AGREEMENT
(this “Agreement”), dated as of January 31, 2022, is entered into by and among CRYSTAL GLOBE LIMITED, a company incorporated
and existing under the law of British Virgin Islands (the “Seller”), JHP HOLDINGS, INC., a Nevada corporation (the
“Buyer”) and JOWAY HEALTH INDUSTRIES GROUP INC., a Nevada corporation (the “Company”).

 

WITNESSETH:

 

WHEREAS, the Buyer desires
to purchase, and the Seller desires to sell, sixteen million six hundred forty four thousand eight hundred twenty (16,644,820) restricted
shares (the “Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”),
representing eighty three (83%) percent of the outstanding shares of Common Stock of the Company on a fully diluted basis, for an aggregate
purchase price of $100,000; and

 

NOW, THEREFORE, in consideration
of the promises and the mutual covenants, representations and warranties contained herein, and other good and valuable consideration,
the receipt and sufficient of which is hereby acknowledged, the parties hereto hereby agree as follows:

 

1.
SALE AND PURCHASE OF THE SHARES. Subject to the terms and conditions of this Agreement, at the Closing (as defined
in Section 2.1 below) to be held pursuant to Section 2 below, the Seller shall sell, assign, transfer, convey and deliver to the Buyer,
and the Buyer shall purchase and acquire from the Seller, good and marketable title to the Shares, free and clear of all Liens (as defined
in Section 3.1 below), except that the Shares constitute “restricted securities” as defined in the Securities Act of 1933,
as amended (the “Securities Act”). The purchase price for the Shares shall be $100,000 (the “Purchase Price”).

 

2.
THE CLOSING.

 

2.1   Place
and Time. The closing of the sale and purchase of the Shares (the “Closing”) shall take place simultaneous
with the execution and delivery of this Agreement or on such date (the “Closing Date”) and time as the parties shall
so agree.

 

2.2   Deliveries
by the Seller. At the Closing, the Seller shall deliver to the Buyer or to its agent or representative the following:

 

(a)   an
original stock certificate representing the Shares, along with a stock power, duly endorsed in blank, sufficient to transfer the Shares
from the Seller to the Buyer;

 

(b) an irrevocable instruction
letter to the Company’s transfer agent directing the transfer agent to register the Shares in the name of the Buyer on the books
of the Company, and any other documentation required by the Company’s transfer agent;

 

(c)   a
copy of this Agreement, duly executed by the Seller;

 

     

     

    

 

(d)   resolutions
of the board of directors and shareholders of the Seller authorizing all transactions contemplated by this Agreement; and

 

(e)   all
other documents, instruments and writings reasonably requested by the Buyer to be delivered by the Seller at the Closing.

 

2.3   Deliveries
by the Company. At the Closing, the Company shall deliver to counsel for the Buyer the following:

 

(a)
a copy of this Agreement, duly executed by the Company;

 

(b)
evidence, satisfactory to the Buyer, that the Company has no Liabilities (as defined in Section 4.8);

 

(c)
the Company’s original minute books containing the resolutions and actions by written consent of the directors and shareholders
of the Company and the Company’s other original books and records;

 

(d)
the Company’s financial and accounting records (including the Company’s general ledger), all banking records and federal
and state tax and other regulatory filings and filing codes (including SEC EDGAR filing codes and OTC Markets password) in whatever media
they exist, including paper and electronic media;

 

(e)
evidence, satisfactory to the Buyer, that the Seller has assumed all Liabilities of Dynamic Elite International Limited (“Dynamic”)
and its subsidiaries;

 

(f)
a current shareholders’ list from the Company’s transfer agent;

 

(g)
a certificate issued by the Secretary of State of the State of Nevada as to the good standing of the Company as of a date no later
than two business days prior to the Closing;

 

(h)
resolutions of the board of directors of the Company authorizing all transactions contemplated by this Agreement, including, without
limitation, the appointment of the officers and directors as provided for in this Agreement;

 

(i)
duly executed resignation of the officer and director of the Company, effective as of the Closing Date; and

 

(j)
all other documents, instruments and writings required by this Agreement to be delivered by the Company at the Closing and any
other related documents requested by Buyer or its counsel in connection with this Agreement.

 

2.4   Deliveries
by the Buyer. At the Closing, the Buyer shall deliver, or cause to be delivered, to the Seller:

 

(a)   the
full Purchase Price, payable by a wire transfer to an account designed prior to Closing by Seller;

 

    2

     

    

 

(b) the names of the officers
and directors of the Company nominated by the Buyer as of the date of Closing, and any other information requested by the Seller or its
counsel in connection with this Agreement; and  

 

(c)   a
copy of this Agreement duly executed by the Buyer.

 

3.
REPRESENTATIONS AND WARRANTIES OF THE SELLER. 

 

The Seller represents, warrants
and covenants to the Buyer and the Company, as of the date of this Agreement and the Closing (in the event such dates are different),
as follows:

 

3.1   Ownership
of Shares. Seller has been the sole record and beneficial owner of the Shares since it initially acquired the Shares and has the
sole power over the disposition of the Shares. The Shares are free and clear of any liens,
encumbrances, objections, title defects, security interest, pledges, mortgages, charges, claims, options, preferential arrangements or
restrictions of any kind, including but not limited to any restriction on the use, voting, transfer or other exercise of any attributes
of ownership (collectively, “Liens”), other than applicable securities laws and regulations. Seller is not a
party to any proxy, option, warrant, voting trust, right of first refusal or any other contract or agreement with respect to the voting,
redemption, sale, transfer or other disposition of the Shares. Upon the Closing,
the Buyer will own 83% of the issued and outstanding share capital of the Company on a fully-diluted basis, free and clear of any Liens,
other than those imposed by applicable federal and state securities laws. 

 

3.2   No
Other Transfers or Interests. Neither the Shares nor any interest therein has been sold, conveyed, encumbered, hypothecated or
otherwise transferred by Seller except pursuant to this Agreement. As of the Closing, neither Seller nor any of its affiliates will have
any interest, direct or indirect, in any shares of capital stock or other equity in the Company or have any other direct or indirect interest
in any tangible or intangible property which the Company uses or has used in the business conducted by the Company, or has any direct
or indirect outstanding indebtedness to or from the Company, or related, directly or indirectly, to its assets.

 

3.3   Authorization;
Enforceability. Seller has the legal right to enter into and to consummate the transactions contemplated hereby, to perform its
covenants and otherwise to carry out Seller’s obligations hereunder. This Agreement and any related agreements or instruments, upon
execution and delivery by the Seller (and assuming due execution and delivery hereof and thereof by the Company and the Buyer hereto),
will constitute a valid and legally binding obligation of the Seller, enforceable against the Seller in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law

 

    3

     

    

 

3.4   No
Breach. Neither the execution and delivery of this Agreement nor compliance by the Seller with any of the provisions hereof nor
the consummation of the transactions and actions contemplated hereby will:

 

(a)
conflict with or violate any provision of the Seller’s Memorandum of Association, By-laws or other organizational or charter
documents;

 

(b)
violate or, alone or with notice of the passage of time, result in the breach or termination of, or otherwise give any contracting
party the right to terminate, or declare a default under, the terms of any agreement or other document or undertaking, oral or written
to which the Seller is a party;

 

(c)
result in the creation of any Lien upon any of the properties or assets of the Seller, including without limitation, the Shares;
or

 

(d)
violate any law or regulation of any jurisdiction relating to the Seller or the Shares or violate any statute, ordinance, order,
injunction, decree or award of any court or governmental or quasi-governmental agency against, or binding upon the Seller or any of its
assets.

 

3.5   No
Consents; No Litigation. The Seller is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other person
or entity in connection with the execution, delivery and performance by the Seller of this Agreement. There is no suit, action, or legal,
administrative, arbitration or other proceeding or governmental investigation pending or threatened against, affecting or which will affect,
the property of the Seller.

 

3.6   No
General Solicitation or Advertisement. Neither the Seller, nor any person acting on Seller’s behalf, has offered or sold
the Shares by any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act).

 

3.7   Experience
and Knowledge. Seller acknowledges and agrees that it has extensive knowledge and experience in financial and business matters;
has made its own inquiry and investigation into, and, based thereon, has formed an independent judgment concerning, the sale of the Shares
to the Buyer; and has received sufficient and satisfactory answers to any questions posed to evaluate the merits and risks of the transactions
contemplated by this Agreement.

 

3.8   Arms’
Length. Seller hereby acknowledges and agrees that the sale of the Shares is taking place in a private transaction between Seller
and the Buyer in an arms’ length commercial transaction at a price negotiated and agreed to by Seller. The Seller is solely responsible
for making its own judgments in connection with this Agreement; and the Buyer has not rendered advisory services of any nature or respect,
nor owes any agency, fiduciary or other duty to the Seller, in connection with the transactions contemplated hereby or the process leading
thereto.

 

3.9   Appreciation
of Shares. Seller understands and acknowledges that if the Company makes certain changes to its business plan, such changes could
have a material positive effect on the future value of the Company, and in particular on the value of the Shares being sold pursuant to
this Agreement. Seller understands and acknowledges that the Shares could appreciate considerably in value in the near or long term and
regardless thereof agrees to sell the Shares at the Purchase Price pursuant to this Agreement.

 

    4

     

    

 

3.10   Company
Disclosures. Seller has no knowledge of a material fact about the operations, affairs, condition or prospects of the business
or the financial condition of the Company or the market for the Company’s securities that has not been publicly disclosed by the
Company, other than the transactions contemplated herein.

 

4.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company and the
Seller each represents, warrants and covenants to the Buyer as of the date of this Agreement and as of the Closing Date (in the event
such dates are different), as follows:

 

4.1   Organization
and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the laws of the state
of Nevada. The Company has all requisite power, right and authority to execute, deliver and perform its obligations under this Agreement
and to carry out the transactions contemplated hereby and thereby. All actions on the part of the Company and its officers and directors
necessary for the authorization, execution, delivery and performance of this Agreement, the consummation of the transactions contemplated
hereby and thereby, and the performance of all of the Company’s obligations under this Agreement have been taken or will be taken prior
to the Closing.

 

4.2   The
Shares. The Shares are duly and validly issued, fully paid and non-assessable. The Shares are not subject to any Liens, other
than applicable securities laws and regulations, or any proxy, option, warrant, voting trust, right of first refusal or any other contract
or agreement with respect to the voting, redemption, sale, transfer or other disposition of the Shares.

 

4.3   Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by its board of directors in connection herewith. This Agreement constitutes the valid
and binding obligation of the Company, and enforceable against it in accordance with its terms, except: (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

4.4   No
Conflicts. The execution, delivery and performance by the Company of this Agreement, the issuance and sale of the Shares and the
consummation by it of the transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company’s
Articles of Incorporation, By-laws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties
or assets of the Company, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice,
lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other
understanding to which the Company is a party or by which any property or asset of the Company is bound or affected, or (iii) conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company is the owner (including federal and state securities laws and regulations), or by which any property or
asset of the Company is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a material adverse effect on the assets, business, condition (financial or otherwise), results of operations
or future prospects of the Company.

 

    5

     

    

 

4.5 SEC
Filings. The Company has filed all reports with the Securities and Exchange Commission (the “SEC”) and
other materials required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), as applicable, during the preceding six years (collectively, the “SEC
Filings”), and all such SEC Filings are incorporated herein by reference. As of their respective dates, the SEC Filings
complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable. The financial
statements included in the SEC Filings comply in all material respects with applicable accounting requirements and the rules and
regulations of the SEC with respect thereto as in effect at the time of filing. The
Company is a “shell company”, as defined in Rule 12b-2 under the Exchange Act.

 

4.6 Capitalization.
The total authorized and issued capital stock of the Company as of the date of this Agreement is, and as of the Closing Date shall be,
200,000,000 authorized, of which 20,054,000 are outstanding, and 1,000,000 shares of preferred stock, none of which are issued or outstanding.
Each holder of Common Stock issued by the Company is entitled to cast one vote
for each share held on all matters properly submitted to the shareholders for their vote; and there are no pre-preemptive rights and no
cumulative voting. The Company has no shares reserved for issuance pursuant to any stock option plan or pursuant to securities exercisable
for, or convertible into or exchangeable for shares of Common Stock. All of the issued and outstanding shares of capital stock of the
Company, including without limitation, the Shares, (i) are duly authorized, validly issued, fully paid and nonassessable and (ii) were
issued in compliance with all applicable securities laws. No shares of capital stock of Company are subject to preemptive rights or any
other similar rights. There are (i) no outstanding options, warrants, scrip, rights to subscribe for, puts, calls, rights of first refusal,
agreements, understandings, claims or other commitments or rights of any character whatsoever relating to, or securities or rights convertible
into or exchangeable for any shares of capital stock of the Company or arrangements by which the Company is or may become bound to issue
additional shares of capital stock of the Company, (ii) no agreements or arrangements under which the Company is obligated to register
the sale of any of its or their securities under the Securities Act and (iii) no anti-dilution or price adjustment provisions contained
in any security issued by the Company (or in any agreement providing any such rights). The Shares are free and clear of all Liens. Neither
the Company nor any of its shareholders is a party to any agreement, voting trust, proxy, option, right of first refusal or any other
agreement or understanding with respect to the Common Stock. 

 

    6

     

    

 

4.7   Consents
and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make
any filing or registration with, any court or other federal, state, local or other governmental authority or other person or entity in
connection with the execution, delivery and performance by the Company of this Agreement, other than the filing of a Current Report on
Form 8-K with the SEC. Assuming the accuracy of the Buyer’s representations and warranties set forth in Section 5, no registration
under the Securities Act is required for the sale of the Shares by the Seller to the Buyer as contemplated hereby.

 

4.8   Liabilities.
As of the Closing Date, there will be no liabilities, debts or obligations of the Company, whether accrued, absolute, contingent or otherwise
(the “Liabilities”). The Liabilities of Dynamic and the other subsidiaries of the Company have been assumed in their
entirety by the Seller. The Company shall provide evidence satisfactory to Buyer that all Liabilities incurred prior to the Closing Date
shall have been paid in full, including without limitation, the payment of the Merger Consideration (as such term is defined in the Merger
Agreement) and all other Liabilities incurred in connection with the transactions contemplated by the Merger Agreement. The Company has
filed all federal, state and local tax returns which are required to be filed by it, through and including the date hereof and as of the
Closing date, including, but not limited to, its federal income tax returns and all taxes shown to be due thereon (together with any applicable
penalties and interest) have been paid. The Company has not incurred any liability for taxes except in the ordinary course of business.
The Company has paid or provided adequate reserves for all taxes which have become due for all periods prior to the date of this Agreement
or pursuant to any assessments received by it or which the Company is obligated to withhold from amounts owing to any employee, creditor
or other third party as at or with respect to any period prior to the date of this Agreement. The federal income tax returns of the Company
have never been audited by the Internal Revenue Service or any state regulatory authority. The Company has not waived any statute of limitations
in respect of taxes, nor agreed to any extension of time with respect to a tax assessment or deficiency.

 

4.9 Actions and Proceedings.
Neither the Seller nor the Company is subject to any outstanding orders, writs, injunctions or decrees of any court or arbitration tribunal
or any governmental department, commission, board, agency or instrumentality, domestic or foreign, against, involving or affecting the
business, properties or employees of the Company or the Seller, including without limitation, their respective right to enter into, execute
and perform this Agreement (or any of the transactions contemplated hereby). There are no actions, suits, claims or legal, administrative
or arbitration proceedings or investigations, including any warranty or product liability claims relating to or arising out of the business,
properties or employees of the Company pending or threatened against or affecting the Company or the Seller.

 

4.10    Compliance
with Laws. The Company has complied in all respects with all laws, ordinances, regulations and orders applicable to the conduct
of its business, including all laws relating to environmental matters, employees and working conditions. There are no actions, suits,
proceedings, or governmental investigations (or any investigation of any self-regulatory organization) relating to the Company or to any
of its properties, assets or businesses pending or threatened, or any order, injunction, award or decree outstanding against the Company
or against or relating to any of its properties, assets or businesses. The Company is not in violation of any law, regulation, ordinance,
order, injunction, decree, award or other requirements of any governmental body, court or arbitrator relating to its properties, assets
or business.

 

    7

     

    

 

4.11    Bank
Accounts and Credit Cards. At Closing, the Company will not have any bank account, safe deposit box or credit or charge cards.
All bank statements have or will be provided to Buyer on or prior to the Closing.

 

4.12    Stockholders.
Attached hereto as Schedule 4.12 is a current stockholder list as provided by the Company’s transfer agent.

 

4.13    Subsidiaries.
As of the Closing Date, the Company shall not own any voting securities or other interests of any corporation, partnership or other business
entity, or possess, directly or indirectly, the power to direct or cause the direction of the management and policies of any corporation,
partnership or other business entity, whether through the ownership of voting shares, by contract or otherwise. The transactions contemplated
by the Merger Agreement shall be completed in their entirety and the Company shall have no further obligation or responsibility in connection
therewith, including than the payment of the Merger Consideration (as such term is defined in the Merger Agreement) to the shareholders
of the Company.

 

4.14    Agreements
and Obligations; Performance. As of the Closing, the Company shall not be a party to, or bound by any contract, arrangement, commitment
or understanding of any kind with any person, including without limitation, any (i) contract, arrangement, commitment or understanding
with its customers or any officer, employee, stockholder, director, representative or agent thereof; (ii) contract for the purchase or
sale of any services, materials, products or supplies; (iii) contract of employment with any officer, employee, consultant or agent; (iv)
deferred compensation, bonus or incentive plan or agreement: (v) management or consulting agreement; (vi) lease for real or personal property
(including borrowings thereon), license or royalty agreement; (vii) union or other collective bargaining agreement; (viii) agreement,
commitment or understanding relating directly or indirectly to Liability on behalf of the Company; and (ix) contract, agreement, commitment
or understanding which affects any of its properties, assets or business, whether directly or indirectly.

 

4.15    Permits
and Licenses. The Company is in compliance in all respects with all requirements, standards and procedures of the federal, state,
local and foreign governmental bodies which issued such permits, licenses, orders, franchises and approvals.

 

4.16   Employee
Benefit Plans. The Company does not maintain and is not required to make contributions to any “pension” and “welfare”
benefit plans (within the respective meanings of Sections 4(2) and 4(1) of the Employee Retirement Income Security Act of 1974, as amended).

 

4.17   Trading.
The shares of Common Stock are quoted on the OTC Pink under the symbol “GTVI” [and the shares of Common Stock are eligible
for deposit with the DTC]. The Company has not received any correspondence and/or notice (nor has any reason to believe it will in the
future receive) regarding the continued eligibility of the Common Stock to be quoted on the OTC Pink or deposited with the DTC.

 

4.18   Insurance.
The Company has no insurance policies.

 

    8

     

    

 

4.19   Sarbanes-Oxley.
The Company (i) makes and keeps accurate books and records and (ii) maintain and has maintained effective internal control over financial
reporting as defined in Rule 13a-15 under the Exchange Act and a system of internal accounting controls sufficient to provide reasonable
assurance that (A) transactions are executed in accordance with management’s general or specific authorization, (B) transactions
are recorded as necessary to permit preparation of the Company’s financial statements in conformity with accounting principles generally
accepted in the United States and to maintain accountability for its assets, (C) access to the Company’s assets is permitted only
in accordance with management’s general or specific authorization and (D) the recorded accountability for the Company’s assets
is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company
has established and maintains disclosure controls and procedures (as such term is defined in Rule 13a-15 under the Exchange Act), (ii)
such disclosure controls and procedures are designed to ensure that the information required to be disclosed by the Company in the reports
it will file or submit under the Exchange Act is accumulated and communicated to management of the Company, including its principal executive
officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure to be made and (iii)
such disclosure controls and procedures are effective in all material respects to perform the functions for which they were established.
There is and has been no failure on the part of the Company and any of the Company’s directors or officers, in their capacities
as such, to comply with the provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith.

 

4.20   Internal
Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance
that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain
asset accountability, and (iii) the recorded amounts for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences.

 

4.21   Disclosure.
Neither this Agreement, nor any certificate, exhibit, or other written document or statement, furnished to the Buyer by the Seller and/or
the Company in connection with the transactions contemplated by this Agreement contains or will contain any untrue statement of a material
fact or omits or will omit to state a material fact necessary to be stated in order to make the statements contained herein or therein
not misleading.

 

5.   REPRESENTATIONS
AND WARRANTIES OF THE BUYER. The Buyer represents, warrants and covenants to the Company, as of the date of this Agreement and as
of the Closing Date (in the event such dates are different), as follows:

 

5.1   Authorization;
Enforceability. Buyer has the legal right to enter into and to consummate the transactions contemplated hereby and otherwise to
carry out Buyer’s obligations hereunder. The execution, delivery and performance by the Buyer of this Agreement has been duly authorized
by all requisite action by the Buyer, and the Agreement, when executed and delivered by the Buyer, constitutes a valid and binding obligation
of the Buyer, enforceable against the Buyer in accordance with its terms, except: (i) as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights
generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies
and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

    9

     

    

 

5.2   No
Breach. Neither the execution and delivery of this Agreement nor compliance by the Buyer with any of the provisions hereof nor
the consummation of the transactions and actions contemplated hereby will:

 

(a)   violate
or, alone or with notice of the passage of time, result in the material breach or termination of, or otherwise give any contracting party
the right to terminate, or declare a material default under, the terms of any agreement or other document or undertaking, oral or written
to which the Buyer is a party;

 

(b)   result
in the creation of any lien, security interest, charge or encumbrance upon any of the properties or assets of the Buyer, including without
limitation, the Shares, pursuant to the terms of any agreement or instrument; or

 

(c)   violate
any law or regulation of any jurisdiction relating to the Buyer or the Shares or violate any statute, ordinance, order, injunction, decree
or award of any court or governmental or quasi-governmental agency against, or binding upon the Seller.

 

5.3   No
Litigation, Etc. There is no suit, action, or legal, administrative, arbitration or other proceeding or governmental investigation
pending or, to the Buyer’s best knowledge, threatened against, affecting or which will materially affect, the property of the Buyer.

 

5.4.   Experience
and Knowledge. Buyer has extensive knowledge and experience in financial and business matters; has made its own inquiry and investigation
into, and, based thereon, has formed an independent judgment concerning the operations of the Company, its business and prospects; has
received sufficient and satisfactory answers to any questions to evaluate the merits and risks of the transactions contemplated by this
Agreement; has adequate means of providing for the Buyer’s current financial needs and foreseeable contingencies and has no need
for liquidity of its investment in the Shares for an indefinite period of time; and is aware that an investment in the Shares involves
a number of very significant risks.

 

5.5   No
General Solicitation or Advertisement. Neither the Buyer, nor any person acting on Buyer’s behalf, has offered to purchase
the Shares from the Seller by any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities
Act).

 

5.7   Restricted
Securities. The Buyer understands that the Shares have not been registered under the Securities Act and is purchasing the Shares
in reliance upon the applicable exemptions from the registration provisions of the Securities Act which depend upon, among other things,
the bona fide nature of the investment intent and the accuracy of the Buyer’s representations as expressed herein. The Buyer understands
that the Shares constitute “restricted securities” under applicable U.S. federal and state securities laws and that, pursuant
to these laws, the Buyer must hold the Shares indefinitely unless they are registered with the SEC and qualified by state authorities,
or an exemption from such registration and qualification requirements is available.

 

    10

     

    

 

5.8   Shell
Status. The Buyer expressly acknowledges that it is aware that the Company is a “shell company” (as such term is defined
in Rule 12b-2 under the Exchange Act), and that the resale of the Securities purchased herein are subject to the additional requirements
under Rule 144(i)(2), namely that: (a) the Company would need to be subject to the reporting requirements of Section 13 or 15(d) of the
Exchange Act; (b) the Company would need to have filed all reports and other materials required to be filed by Section 13 or 15(d) of
the Exchange Act, as applicable, during the preceding 12 months (or for such shorter period that the issuer was required to file such
reports and materials), other than Form 8-K reports; and (c) a full twelve months would need to have passed after the Company filed current
“Form 10 information” with the Commission reflecting its status as an entity that is no longer a shell company. 

 

5.9   Legend.
The Buyer understands that the Shares shall bear the following legend, or one substantially similar thereto:

 

“These securities have
not been registered under the Securities Act of 1933, as amended (the “Securities Act”). These securities have been
acquired for investment and may not be sold, transferred or assigned in the absence of an effective registration statement for those shares
under the Securities Act, or an opinion satisfactory to the Company’s counsel that registration is not required under said Securities
Act.”

 

5.10   Arms’
Length. Buyer hereby acknowledges and agrees that the purchase of the Shares is taking place in a private transaction between
Seller and the Buyer in an arms’ length commercial transaction at a price negotiated and agreed to by Seller. The Buyer is solely
responsible for making its own judgments in connection with this Agreement; and the Seller has not rendered advisory services of any nature
or respect, nor owes any agency, fiduciary or other duty to the Buyer, in connection with the transactions contemplated hereby or the
process leading thereto.

 

5.11   No
Governmental Review. Buyer understands that no United States federal or state agency or any other government or governmental agency
has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of the investment in the Shares,
nor have such authorities passed upon or endorsed the merits of the offering of the Shares.

 

 6. PRE-CLOSING COVENANTS AND AGREEMENTS OF THE PARTIES.

 

The Seller and the Company
hereby covenant and agree that, from the date hereof and until the Closing, if such dates are different:

 

 6.1 Access.
The Company and the Seller shall afford the officers, attorneys, accountants and other authorized representatives of the Buyer free and
full access, during regular business hours and upon reasonable notice, to their respective books, records, personnel and properties (including,
without limitation, the work papers prepared by its auditors) so that the Buyer may have full opportunity to make such review, examination
and investigation as it may desire. Each of the Seller and the Company will cause its employees, accountants and attorneys to cooperate
fully with said review, examination and investigation and to make full disclosure to the Buyer of all material facts affecting the Company
and the Shares.

 

    11

     

    

 

6.2   Liabilities.
The Company shall not incur any Liabilities, absolute and continent, except in the ordinary course of business. On the Closing Date, (i)
the Company shall have no Liabilities and (ii) the Seller shall assume all Liabilities relating to the operation and business of the Seller
and its subsidiaries for all periods prior to the Closing.

 

6.3   No
Breach. Each of the parties hereto will (i) use its best efforts to assure that all of its respective representations and warrants
contained herein are true in all material respects at and as of the date hereof, and as of the Closing Date, no breach shall occur with
respect to any of the parties’ covenants, representations or warranties contained herein that has not been cured by the Closing; (ii)
not voluntarily take any action or do anything which will cause a material breach of or default respecting such covenants, representations
or warranties; and (iii) promptly notify the other of any event or fact which represents a breach or default.

 

6.4   Public
Announcements. No party hereunder shall, without the express prior written consent of the other, make any announcement or otherwise
disclose any information regarding this Agreement and/or the transactions contemplated hereby other than as required by law or otherwise
deemed advisable in the opinion of counsel to the Buyer or the Seller to ensure compliance with public disclosure requirements under federal
securities laws.

 

6.5   Expenses.
Each of the parties hereto agrees to bear its own expenses in connection with the negotiation, preparation, execution and delivery of
this Agreement and the consummation of the transaction contemplated hereby.

 

6.6   Exclusivity.
Until the earlier of the Closing or the termination of this Agreement in accordance with Article XI hereof, neither Seller nor the Company
shall directly or indirectly solicit, initiate, encourage or entertain any inquiries or proposals from, discuss or negotiate with, provide
any nonpublic information to or consider the merits of any inquiries or proposals from any person (other than Buyer) relating to the Shares
or a business combination transaction involving Seller and/or the Company, including but not limited to the sale of stock, the merger
or consolidation of Seller or the Company, or the sale of business or assets of Seller or the Company. Seller shall notify Buyer of any
such inquiry or proposal from any third party within twenty-four (24) hours of receipt or awareness of the same by Seller or the Company.

 

6.7   Further
Assurances. Each of the parties shall execute such documents or other papers and take such further actions as may be reasonably
required or desirable to carry out the provisions hereof and the transactions contemplated in this Agreement.

 

 7. CONDITONS PRECEDENT TO THE OBLIGATIONS OF THE BUYER.

 

The obligations of the Buyer
to effectuate the Closing are subject to the fulfillment, prior to the date of Closing, of each of the following conditions (any one or
more of which may be waived by the Buyer unless such condition is a requirement of law):

 

7.1   Representations
and Warranties. All representations and warranties of the Company and the Seller contained in this Agreement and in any written
statement, schedule or other documents delivered pursuant hereto or in connection with the transactions contemplated hereby shall be true
and correct in all respects as of the date hereof and as of the Closing Date, as applicable.

 

    12

     

    

 

7.2   Covenants.
The Company and the Seller shall have performed and complied in all respects with all covenants and other agreements required by (or contained
in) this Agreement to be performed or complied with or by them prior to or at the Closing Date.

 

7.3   No
Actions. No action, suit, proceeding or investigation shall have been instituted against the Seller or the Company, and be continuing
before a court or before or by a governmental body or agency, and be unresolved, to restrain or to prevent or to obtain damages in respect
of, the carrying out of the transactions contemplated hereby or which might materially and adversely affect the rights of the Buyer to
consummate the transactions contemplated hereby.

 

7.4   Approvals.
The Seller and the Company shall have obtained all approvals and consents to consummate this Agreement and the transactions to be consummated
at or immediately following the Closing, in accordance with all applicable laws, rules and regulations.

 

7.5   Due
Diligence. The Buyer shall have completed to its sole satisfaction its due diligence of the Company and all other items it deems
necessary and/or advisable, and shall be satisfied with the results thereof, including without limitation, that all Liabilities have been
paid or satisfied in full.

 

7.6   Closing
Documents. The Buyer shall receive all of the documents (executed where applicable) set forth in Section 2.2 and Section 2.3 of
this Agreement, which documents shall be in form and substance reasonably satisfactory to Buyer and their legal counsel.

 

7.7   Resignation
of Directors and Officers. Effective on the Closing Date, all officers and directors of the Company shall have resigned and the
Company shall have duly appointed the nominees of the Buyer as a director and President and Secretary and Treasurer, respectively, of
the Company.

 

 8. CONDITIONS PRECEDENT TO THE OBLIGATION TO THE COMPANY AND THE SELLER TO CLOSE.

 

The obligations of the Company
and the Seller to effectuate the Closing is subject to the fulfillment, prior to the date of Closing, of each of the following conditions
(any one or more of which may be waived by the Buyer unless such condition is a requirement of law):

 

8.1   Representations
and Warranties. All representations and warranties of the Buyer contained in this Agreement and in any written statement or other
documents delivered pursuant hereto or in connection with the transactions contemplated hereby shall be true and correct in all material
respects as of the date hereof and as of the Closing Date.

 

    13

     

    

 

8.2   Covenants.
The Buyer shall have performed and complied in all material respects with all covenants and other agreements required by (or contained
in) this Agreement to be performed or complied with by it prior to or at the Closing.

 

8.3   No
Actions. No action, suit, proceeding or investigation shall have been instituted against the Buyer, and be continuing before a
court or before or by a governmental body or agency, and be unresolved, to restrain or to prevent or to obtain damages in respect of,
the carrying out of the transactions contemplated hereby, or which might materially and adversely affect the rights of the Seller and
the Company to consummate the transactions contemplated hereby.

 

8.4   Approvals.
The Buyer shall have obtained all required consents and approvals to this Agreement and the transactions to be consummated at or immediately
following the Closing, in accordance with all applicable laws, rules and regulations.

 

8.5   Purchase
Price. The Seller shall receive the Purchase Price.

 

 9. INDEMNIFICATION AND GUARANTY.

 

9.1   Indemnification.
Each of the Seller and the Company shall indemnify and hold the Buyer and its agents, representatives, designees and affiliates harmless
from and against any loss, damage or expense (including reasonable attorneys’ fees and expenses) caused by or arising out of any claim
made against such party:

 

(a)
for any broker’s or finder’s fee or any similar fee, charge or commission incurred by the Seller prior to or in connection with
this Agreement or the transaction contemplated hereby;

 

(b)
for any Liability of the Seller and/or the Company otherwise incurred on or before the Closing, including, without limitation,
with respect to the execution and performance of this Agreement or the Merger Agreement;

 

(c)
for any Liability of the Seller and/or the Company in connection with the Merger Agreement and the transactions contemplated thereby;

 

(d)
for any Liability of the Seller, Dynamic or any of their respective affiliates, employees, officers, directors, shareholders, agents
and representatives after the Closing Date; and

 

(e)
for (i) any inaccuracy or breach of any of the representations and warranties of the Seller or the Company in this Agreement or
in any certificate or document delivered by or on behalf of the Seller or the Company pursuant to this Agreement, or any actions, omissions
or statements of fact inconsistent with in any respect any such representation or warranty, or (b) any failure by the Seller or the Company
to perform or comply with any agreement, covenant or obligation in this Agreement or in any certificate or document delivered by or on
behalf of the Seller or the Company pursuant to this Agreement to be performed by or complied with by or on behalf of the Seller or the
Company.

 

    14

     

    

 

9.2   Notice
and Opportunity to Defend. Promptly after the receipt by the Buyer of notice of any action, proceeding, claim or potential claim
(any of which is hereinafter individually referred to as a “Circumstance”) which could give rise to a right to indemnification
under this Agreement, Buyer (the “Indemnified Party”) shall give prompt written notice to the party or parties who
may become obligated to provide indemnification hereunder (the “Indemnifying Party”). Such notice shall specify in
reasonable detail the basis and amount, if ascertainable, of any claim that would be based upon the Circumstance. The Indemnifying Party
shall have the right, at its option, to compromise or defend the claim, at its own expense and by its own counsel, and otherwise control
any such matter involving the asserted liability of the Indemnified Party, provided that any such compromise or control shall be subject
to obtaining the prior written consent of the Indemnified Party. If any Indemnifying Party undertakes to compromise or defend any asserted
liability, it shall promptly notify the Indemnified Party of its intention to do so, and the Indemnified Party agrees to cooperate fully
with the Indemnifying Party and its counsel in the compromise of or defense against any such asserted liability. All costs and expenses
incurred in connection with such cooperation shall be borne by the Indemnifying Party. In any event, the Indemnified Party shall have
the right at its own expense to participate in the defense of an asserted liability.

 

9.3   Guaranty.
For and in consideration of the Purchase Price and the covenants and promises contained herein and other valuable consideration, the receipt
and sufficiency of which are hereby acknowledged by the Seller, effective upon the Closing, the Seller, on behalf of itself and its successors,
assigns, representatives and agents, hereby unconditionally and irrevocably guarantees all of the obligations and Liabilities of the Company
and Dynamic incurred prior to the Closing Date, whether for commissions, expenses, liquidated damages, indemnifications or otherwise,
and agrees to pay any and all costs, fees and expenses (including counsel fees and expenses) in connection therewith, including without
limitation, the indemnification provisions set forth in Section 9.1 above. The liability of Seller hereunder constitutes a primary obligation,
and not a contract of surety, and to the extent permitted by law, shall be irrevocable, absolute and unconditional irrespective of, and
Seller hereby irrevocably waives any defenses it may now or hereafter have in any way relating to, any or all of the Liabilities.

 

10.   MISCELLANEOUS.

 

10.1   Successors
and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective heirs,
successors and assigns. No assignment of this Agreement or of any rights hereunder shall relieve the assigning party of any of its obligations
or liabilities hereunder.

 

10.2   Notices.
 All notices or other communications required or permitted to be given hereunder shall be in writing and shall be deemed to have
been duly given if delivered by hand, overnight courier, email, facsimile transmission or prepaid cable or telegram and confirmed in writing,
or mailed first class, postage prepaid, by registered or certified mail, return receipt requested (mailed notices and notices sent by
facsimile transmission, cable or telegram shall be deemed to have been given on the date sent) to the address of the parties provided
to each other or in any case to such other address or addresses as hereafter shall be furnished as provided in this Section 10.2 by either
of the parties hereto to the other party hereto.

 

    15

     

    

 

10.3    Waiver;
Remedies. No delay on the part of any of the Seller, the Company or the Buyer in exercising any right, power or privilege hereunder
shall operate as a waiver thereof, nor shall any waiver on the part of the Seller, the Company or the Buyer of any right, power or privilege
hereunder operate as a waiver of any other right, power or privilege hereunder, nor shall any single or partial exercise of any right,
power or privilege hereunder preclude any other or further exercise of any other right, power or privilege hereunder. The rights and remedies
herein provided are cumulative and are not exclusive of any rights or remedies which the parties hereto may otherwise have at law or in
equity.

 

10.4   Entire
Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes
all prior agreements or understandings (in writing, oral or otherwise) of the parties relating thereto. Each of the parties represents,
acknowledges and agrees that this transaction is being made knowingly, intelligently and voluntarily made, and that each of the parties
has discussed this transaction and the consequences thereto with counsel of its own choosing. The parties and their counsel have cooperated
in the drafting and preparation of this Agreement and therefore this Agreement shall not be construed against any party by virtue of its
role as the drafter thereof.

 

10.5    Amendment.
This Agreement may be modified or amended only by written agreement of the parties hereto.

 

10.6    Counterparts.
This Agreement may be executed in any number of counterparts and by facsimile or other electronic transmission, each of which shall be
deemed an original but all of which together shall constitute a single instrument.

 

10.7 Governing Law;
Venue. This Agreement shall be governed by and construed exclusively in accordance with the internal laws of the State of New
York without regard to the conflicts of laws principles thereof. The parties hereto hereby expressly and irrevocably agree that any suit
or proceeding arising directly and/or indirectly pursuant to, arising out of or under this Agreement, shall be brought solely and exclusively
in a federal or state court located in the City of New York. By its execution hereof, the parties hereby expressly covenant and irrevocably
submit to the in personam jurisdiction of the federal and state courts located in the City of New York and agree that any
process in any such action may be served upon any of them personally, or by certified mail or registered mail upon them or their agent,
return receipt requested, with the same full force and effect as if personally served upon them in the City of New York. The parties hereto
expressly and irrevocably waive any claim that any such jurisdiction is not a convenient forum for any such suit or proceeding and any
defense or lack of in personam jurisdiction with respect thereto. In the event of any such action or proceeding, the party
prevailing therein shall be entitled to payment from the other party hereto of its reasonable counsel fees and disbursements in an amount
judicially determined.

 

10.8    Captions.
All Section titles or captions contained in this Agreement, in are for convenience only, shall not be deemed a part of this Agreement
and shall not affect the meaning or interpretation of this Agreement.

 

    16

     

    

 

10.9    Confidential
Information. Each party agrees that such party and its representatives will hold in strict confidence all information and documents
received from the other parties and, if the transactions herein contemplated shall not be consummated, each party will continue to hold
such information and documents in strict confidence and will return to such other party all such documents (including the documents annexed
to this Agreement) then in such receiving party’s possession without retaining copies thereof, provided, however, that each
party’s obligations under this Section 10.9 to maintain such confidentiality shall not apply to any information or documents that are
in the public domain at the time furnished by the others or that become in the public domain thereafter through any means other than as
a result of any act of the receiving party or of its agents, officers, directors or stockholders which constitutes a breach of this Agreement,
or that are required by applicable law to be disclosed.

 

11.   TERMINATION
AND WAIVER

 

11.1    Termination.
Notwithstanding anything herein or elsewhere to the contrary, this Agreement may be terminated and the transactions provided for herein
abandoned at any time prior to the Closing by mutual written consent of the Buyer, the Company and the Seller.

 

11.2    Waiver.
Any condition to the performance of any party hereto which legally may be waived on or prior to the Closing may be waived at any time
by the party entitled to the benefit thereof by action taken or authorized by an instrument in writing executed by the relevant party
or parties. The failure of any party at any time or times to require performance of any provision hereof shall in no manner affect the
right of such party at a later time to enforce the same. No waiver by any party of the breach of any term, covenant, representation or
warranty contained in this Agreement as a condition to such party’s obligations hereunder shall release or affect any liability resulting
from such breach, and no waiver of any nature, whether by conduct or otherwise, in any one or more instances, shall be deemed to be or
construed as a further or continuing waiver of any such condition or of any breach of any other term, covenant, representation or warranty
of this Agreement.

 

Remainder of Page Intentionally
Omitted; Signature Page to Follow

 

    17

     

    

 

 

IN WITNESS WHEREOF, the parties have caused this
Stock Purchase Agreement to be duly executed and delivered on the day and year first above written.

 

	 	COMPANY:
	 	 	 
	 	JOWAY HEALTH INDUSTRIES GROUP INC.
	 	 	 
	 	By:	/s/ Jinghe
    Zhang
	 	Name: 	Jinghe Zhang
	 	Title:	Director
	 	 	 
	 	Address for Notices (after the Closing):
	 	 	 
	 	No. 19 Baowang Road, Baodi Economic
	 	Development Zone, Tianjin, PRC 301800
	 	 	 
	 	SELLER:
	 	 	 
	 	CRYSTAL GLOBE LIMITED
	 	 	 
	 	By:	/s/ Jinghe Zhang
	 	Name:	Jinghe Zhang
	 	Title:	Director
	 	 	 
	 	Address for Notices:
	 	 	 
	 	No. 19 Baowang Road, Baodi Economic
	 	Development Zone, Tianjin, PRC 301800
	 	 	 
	 	BUYER:
	 	 	 
	 	JHP HOLDINGS, INC.
	 	 	 
	 	By:	/s/ Ramon
    Lata
	 	Name:	Ramon Lata
	 	Title:	President
	 	 	 
	 	Address for Notices:

 

 

18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]